ZOMEDICA PHARMACEUTICALS COR's ticker is and the CUSIP is 98979F107. A total of 9 filers reported holding ZOMEDICA PHARMACEUTICALS COR in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $316,000 | +35.0% | 2,872,372 | +192.1% | 0.00% | – |
Q2 2020 | $234,000 | +2027.3% | 983,512 | +3101.0% | 0.00% | – |
Q3 2019 | $11,000 | -88.2% | 30,725 | -92.4% | 0.00% | – |
Q2 2019 | $93,000 | -89.6% | 403,679 | -0.7% | 0.00% | -100.0% |
Q1 2018 | $895,000 | +639.7% | 406,593 | +562.9% | 0.00% | – |
Q4 2017 | $121,000 | – | 61,334 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cambridge Investment Research Advisors, Inc. | 12,079,080 | $27,178,000 | 0.29% |
jvl associates llc | 58,500 | $132,000 | 0.13% |
Sigma Planning Corp | 27,500 | $62,000 | 0.00% |
NORTHWEST WEALTH MANAGEMENT, LLC | 280 | $1,000 | 0.00% |
Tower Research Capital LLC (TRC) | 4,158 | $9,000 | 0.00% |
Ameritas Investment Partners, Inc. | 2,890 | $7,000 | 0.00% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 60,388 | $136,000 | 0.00% |
UBS Group AG | 9,495 | $21,000 | 0.00% |
RHUMBLINE ADVISERS | 31,685 | $71,000 | 0.00% |
BNP PARIBAS FINANCIAL MARKETS | 1,290 | $2,902,000 | 0.00% |